Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy
Siemens Healthineers announced today its Innovance Antithrombin assay has achieved FDA clearance for a new claim allowing it ...
Refined test could improve Parkinson's disease diagnosis
A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from ...
Applied DNA Sciences submits validation package to NYSDOH for bird flu test
Applied DNA Clinical Labs has submitted a validation package to the New York State Department of Health to request ...
Arizona PBS6d
New blood test detects pancreatic cancer early with high accuracy
Researchers have developed an inexpensive blood test that they say can detect pancreatic cancer — even in its early stages.
360Dx9d
UCSD Researchers Develop Microfluidic Adhesion Assay for Earlier Cancer Detection
The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.
Naveris Introduces Advanced NavDx+Gyn™ Test for Early Detection of HPV-Driven Gynecologic Cancers
Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the analytical validation of NavDx+Gyn, an important extension of the NavDx® blood test.
European Medical Journal12d
Breakthrough Nanosensor Test Identifies Pancreatic Cancer Earlier
The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD assay available for clinical use and covered by ...